308. Progressive leukoencephalopathy Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 2 / Drugs : 3 - (DrugBank : 1) / Drug target genes : 5 - Drug target pathway : 1
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Fosigotifator
AbbVie
2023 Phase 1/Phase 2 NCT05757141 Canada;Netherlands;United States
Hematopoetic stem cell transplantation
University of Pittsburgh
2012 - NCT03333200 United States
Palliative care
University of Pittsburgh
2012 - NCT03333200 United States
AbbVie
2023 Phase 1/Phase 2 NCT05757141 Canada;Netherlands;United States
Hematopoetic stem cell transplantation
University of Pittsburgh
2012 - NCT03333200 United States
Palliative care
University of Pittsburgh
2012 - NCT03333200 United States